Monitor for any shareholder opposition to the proposals, particularly the share incentive plan amendment and executive compensation, though the board's unanimous endorsement suggests high approval likelihood.
QURE drugs
QURE drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 27 $17.90entry
- T+1 · 7mo ago +0.84%α +1.32% · $18.05
- T+5 · 7mo ago +15.53%α +15.13% · $20.68
- T+20 · 6mo ago +40.50%α +35.55% · $25.15
- T+60 · 4mo ago +125.59%α +120.81% · $40.38
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
uniQure N.V. (QURE) has filed its definitive proxy statement for the 2026 Annual General Meeting, scheduled for June 10, 2026. The board recommends approval of all 15 proposals, including the reappointment of three non-executive directors, auditor appointment, executive compensation, and a share incentive plan amendment.
Key Financial Metrics
Key Facts
- Annual General Meeting scheduled for June 10, 2026
- Board recommends approval of all 15 proposals
- Proposals include reappointment of three non-executive directors (Madhavan Balachandran, Jack Kaye, Leonard Post)
- Proposal to reauthorize board to repurchase shares
- Proposal to amend Articles of Association to increase authorized share capital
- Proposal to approve advisory vote on frequency of executive compensation votes
Financial Impact
No immediate financial impact from routine proxy proposals
Risk Factors
- Potential shareholder dissent on executive compensation (Proposal 10)
- Possible opposition to increasing authorized share capital (Proposal 14)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-048975 |
| Document: 0001104659-26-048975-index-headers.html | 0001104659-26-048975 |
| Document: 0001104659-26-048975-index.html | 0001104659-26-048975 |
| Document: 0001104659-26-048975.txt | 0001104659-26-048975 |
Track record
38 reports on QURE
6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +27.15% at T+20 after the Jul 29, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $22.79 to $22.71 Now $21.88 −3.99% ▼ −0.35% +0.02% vs SPY
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 6/10 Entry $23.03 to $21.01 Now $21.88 −4.99% ▼ −8.77% −4.36% vs SPY
- Nov 2, 202614d ago 8-K Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Nov 2, 202614d ago Press Release Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Oct 16, 20264w ago SC 13G/A Neutral 3/10 Entry $21.78 to $22.20 Now $21.88 +0.46% ▲ +1.93% +1.51% vs SPY
- Sep 2, 202610w ago 8-K Bullish 7/10 Entry $46.23 to $44.86 Now $21.88 −52.67% ▼ −2.96% −4.01% vs SPY
- Jul 29, 202615w ago 8-K Bullish 8/10 Entry $40.07 to $42.19 Now $21.88 −45.40% ▲ +5.29% +3.61% vs SPY
- Jul 7, 202619w ago Insider Cluster Bearish 5/10 Entry $41.41 to $43.49 Now $21.88 +47.16% ▼ −5.02% −5.33% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 4/10 Entry $41.81 to $41.36 Now $21.88 +47.67% ▲ +1.08% +1.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers